“Hu14.18 has enormous potential to help high-risk neuroblastoma patients, the majority of whom are young children,” she said. “We are now committed to developing this immunotherapy to be ...

The Báa nnilah Health Promotion Program is a seven week program. Participants meet on a weekly basis to discuss strategies to ...

A local charity and community members are gearing up to host the Lights and Ladders Brigade with a mission to deliver holiday ...

The mother of a young boy has revealed how 'unusual' bruising on her son's eyelid led to a life-changing diagnosis.

The Phase III STELLAR trial evaluated the eflornithine and lomustine combination in patients with IDH mutant astrocytoma.

Its flagship drug, Omburtamab, was designed to target central nervous system and leptomeningeal metastases in pediatric neuroblastoma patients. Y-mAbs aimed to commercialize Omburtamab, promoting it ...

Two women from Nettleton, Mississippi, and their families appeared on the "Today Show" to share their daughters’ cancer ...

If we had been asked to really consider that Orli’s time on earth was limited, how would we have used that time? Americans — ...

The Company’s broad and advanced product pipeline includes the anti-GD2 therapy DANYELZA® (naxitamab-gqgk), the first FDA-approved treatment for patients with relapsed or refractory high-risk ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

18, 2024 — A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among high-risk cancer patients ... Nov. 19, 2024 — A study ...